{"@context":"https://schema.org","@type":"Corporation","name":"NATCO PHARMA LTD.","alternateName":"NATCOPHARM","tickerSymbol":"NATCOPHARM","identifier":"NATCOPHARM","description":"NATCO PHARMA LTD. (NATCOPHARM) financials: Market Cap ₹15,400Cr., Price ₹785, P/E 17.3, ROE 16.4%. Jun 2026: sales ₹597 Cr, net profit ₹75 Cr. Quarterly result…","url":"https://fincrux.org/companies/NATCOPHARM","sameAs":["https://fincrux.org/companies/NATCOPHARM"],"dateModified":"2026-10-19T05:50:50.643976","additionalProperty":[{"@type":"PropertyValue","name":"Market Cap","value":"₹15,400Cr."},{"@type":"PropertyValue","name":"Current Price","value":"₹785"},{"@type":"PropertyValue","name":"Stock P/E","value":"17.3"},{"@type":"PropertyValue","name":"ROE","value":"16.4%"},{"@type":"PropertyValue","name":"ROCE","value":"16.8%"},{"@type":"PropertyValue","name":"Book Value","value":"₹436"},{"@type":"PropertyValue","name":"Dividend Yield","value":"0.64%"},{"@type":"PropertyValue","name":"52W High / Low","value":"₹1,217/779"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://fincrux.org/companies/NATCOPHARM#webpage","name":"NATCO PHARMA LTD. (NATCOPHARM) Financials, Quarterly Results & Ratios","url":"https://fincrux.org/companies/NATCOPHARM","isPartOf":{"@id":"https://fincrux.org/#website"}},"publisher":{"@type":"Organization","name":"Fincrux","url":"https://fincrux.org"},"potentialAction":{"@type":"ViewAction","target":"https://fincrux.org/companies/NATCOPHARM"}}